The positive association between mortality and the number of anti‐VEGFA injections in wet AMD patients should be understood as an association between mortality and the severity of the disease and by no means as a direct link between mortality and the dose of an anti‐VEGFA drug. This evidence concerns the gene VEGFA and wet macular degeneration.